We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-7.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$226M
AUM Growth
+$17.5M
(+8.4%)
Cap. Flow
+$40.7M
Cap. Flow
% of AUM
18.02%
Top 10 Holdings %
Top 10 Hldgs %
65.12%
Holding
40
New
13
Increased
11
Reduced
3
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanda Pharmaceuticals
VNDA
|
+$17.6M |
| 2 |
AVTA
Avantax, Inc. Common Stock
AVTA
|
+$10.8M |
| 3 |
APOL
Apollo Education Group Inc Class A
APOL
|
+$10.6M |
| 4 |
Theravance Biopharma
TBPH
|
+$9.39M |
| 5 |
LL
LL Flooring Holdings, Inc.
LL
|
+$9.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$12.9M |
| 2 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
+$10.4M |
| 3 |
SODA
SodaStream International Ltd
SODA
|
+$8.65M |
| 4 |
AEGR
Aegerion Pharmaceuticals
AEGR
|
+$7.79M |
| 5 |
TIME
Time Inc.
TIME
|
+$7.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.6% |
| 2 | Consumer Discretionary | 8.38% |
| 3 | Industrials | 8.03% |
| 4 | Technology | 6.31% |
| 5 | Financials | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $31M | 13.72% |
150,000
+100,000
| +200% | +$20.6M |
|
|
2
Vanda Pharmaceuticals
VNDA
$327M
| $21.2M | 9.41% |
2,284,000
+1,556,000
| +214% | +$17.6M |
|
|
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
| $17.7M | 7.85% |
1,780,000
+266,900
| +18% | +$2M |
|
|
SPPI
4
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $16.4M | 7.26% |
2,700,000
+648,000
| +32% | +$4.31M |
|
5
Kodak
KODK
$750M
| $11.4M | 5.05% |
600,000
+130,000
| +28% | +$2.47M |
|
|
AVTA
6
DELISTED
Avantax, Inc. Common Stock
AVTA
| $10.6M | 4.69% |
+774,000
| New | +$10.8M |
|
|
PBY
7
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
| $10.5M | 4.65% |
1,090,000
+162,000
| +17% | +$1.48M |
|
|
ATRS
8
DELISTED
Antares Pharma, Inc.
ATRS
| $10.3M | 4.56% |
3,800,000
+1,200,000
| +46% | +$3.04M |
|
|
VCRA
9
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $8.99M | 3.98% |
906,000
+56,000
| +7% | +$553K |
|
|
10
Theravance Biopharma
TBPH
$877M
| $8.88M | 3.94% |
+512,000
| New | +$9.39M |
|
|
WIFI
11
DELISTED
Boingo Wireless, Inc.
WIFI
| $8.67M | 3.84% |
1,150,000
+80,000
| +7% | +$621K |
|
|
APOL
12
DELISTED
Apollo Education Group Inc Class A
APOL
| $7.57M | 3.35% |
+400,000
| New | +$10.6M |
|
|
KZ
13
DELISTED
KongZhong Corporation
KZ
| $6.91M | 3.06% |
1,250,000
+53,000
| +4% | +$285K |
|
|
QLGC
14
DELISTED
QLOGIC CORP
QLGC
| $6.9M | 3.06% |
468,000
-174,000
| -27% | -$2.45M |
|
|
PGNX
15
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $6.87M | 3.04% |
+1,148,000
| New | +$7.22M |
|
|
SNAK
16
DELISTED
Inventure Foods, Inc.
SNAK
| $6.71M | 2.98% |
+600,000
| New | +$6.58M |
|
17
Madrigal Pharmaceuticals
MDGL
$12.8B
| $6.29M | 2.79% |
+92,571
| New | +$7.94M |
|
|
PPLI
18
People Inc
PPLI
$3.31B
| $6.07M | 2.69% |
503,587
-212,625
| -30% | -$2.46M |
|
|
LL
19
DELISTED
LL Flooring Holdings, Inc.
LL
| $5.54M | 2.46% |
+180,000
| New | +$9.21M |
|
|
LEAF
20
DELISTED
Leaf Group Ltd.
LEAF
| $5.24M | 2.32% |
+916,000
| New | +$4.7M |
|
21
Veru
VERU
$38.2M
| $3.19M | 1.41% |
112,600
+45,200
| +67% | +$1.58M |
|
22
InspireMD
NSPR
$32.9M
| $2.24M | 0.99% |
+1
| New | +$3.95M |
|
|
BBBY
23
Bed Bath & Beyond
BBBY
$479M
| $1.72M | 0.76% |
+94,501
| New | +$1.64M |
|
|
RPTP
24
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $1.41M | 0.63% |
130,000
-670,000
| -84% | -$6.84M |
|
|
IMUC
25
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $1.2M | 0.53% |
+61,788
| New | +$1.55M |
|
Similar funds
CRC
RMDI
F
DWM
DCP
EW
AIM
O
Armistice Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Armistice Capital held 40 positions worth $226M, up 8.4% from $208M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Armistice Capital deployed $40.7M of net new capital in Q1 2015, opening 13 new positions and adding to 11 existing holdings. Its largest new stake was Avantax, Inc. Common Stock: 774,000 shares worth $10.6M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was RAPTOR PHARMACEUTICAL CORP COM STK (DE), an estimated $6.84M trimmed.
- Armistice Capital's largest Q1 2015 buy was Avantax, Inc. Common Stock: 774,000 shares worth $10.6M.
- Armistice Capital added most to Vanda Pharmaceuticals in Q1 2015, an estimated $17.6M increase.
- Armistice Capital's biggest Q1 2015 reduction was RAPTOR PHARMACEUTICAL CORP COM STK (DE), cutting an estimated $6.84M.
- Armistice Capital fully exited Zogenix, Inc. in Q1 2015, selling an estimated $12.9M.
- Armistice Capital's ten largest holdings make up 65% of its $226M portfolio in Q1 2015.
- Armistice Capital opened 13 new positions and closed 13 in Q1 2015.
- Armistice Capital's portfolio value rose 8.4% quarter-over-quarter to $226M.
Based on Armistice Capital's 13F filing for Q1 2015, filed 15 May 2015.